Phase II trial to evaluate the safety and efficacy of inhaled alpha-1 antitrypsin (AAT) in patients with cystic fibrosis.
Latest Information Update: 31 Mar 2014
At a glance
- Drugs Alpha 1-antitrypsin (Primary)
- Indications Cystic fibrosis
- Focus Therapeutic Use
- Sponsors Kamada
- 24 Mar 2014 New trial record